Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
Ontology highlight
ABSTRACT: The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response toward pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here,
SUBMITTER: Imam T
PROVIDER: S-EPMC5992276 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA